What is it?

Bovilis Nasalgen^®-C is an intranasal, live vaccine which can be used for active immunisation of calves from the day of birth onward to reduce clinical signs of upper respiratory disease and nasal viral shedding from infection with Bovine Coronavirus (BCoV).

Bovilis Nasalgen®-C allows farmers and veterinarians to safely and effectively administer protection against BCoV in a single intranasal vaccination that can quickly reach the site of action. The onset of immunity starts five days after administration, with a 12-week duration. Bovilis Nasalgen®-C can be used concurrently with Bovilis INtranasal RSP® Live.

Why use it:

BCoV is quite prevalent in Irish herds, featuring strongly in calves and is much less prominent in older animals. It likes having a partner in that it is frequently co-detected with other BRD viruses such as Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (PI3).

In terms of bacterial causes of Bovine Respiratory Disease (BRD), it is most commonly detected with Mycoplasma Bovis and Mannheimia Haelmolytica, which can have a long-term impact on the health and productivity of the herd.BRD is the most significant cause of deaths among calves greater than one month of age. BRD has a huge negative impact on growth and performance of both beef and dairy animals. Therefore, Consequences of the disease can manifest later in life with decreased milk production in the first lactation and decreased daily weight gain. For example, a dairy heifer calf can produce up to 120 kg less in her first lactation while beef animals can take up to 2 months longer to finish.

How to use:

Route of Administration: Intranasally

Dose: 2 ml

Calves can be vaccinated with Bovilis Nasalgen-C from the Day of Birth. Vaccinated calves will have protection against respiratory BCoV within 5 days of vaccination. The duration of protection against this virus is 12 weeks.

Bovilis Nasalgen®-C can be used concurrently with Bovilis INtranasal RSP® Live, which offers protection against both BRSV and PI3. Both can be administered from the day of birth, 2 ml into either nostril.

Related Video

To activate the video player please allow cookies in category ‘Performance and Operation’ and refresh this page.

Reducing the risk of pneumonia in calves at turnout
Sarah Higgins MVB MRCVS CertAVP, Ruminant & Equine Veterinary Manager, MSD Animal Health Respiratory disease is commonly seen in both dairy and suckler calves. Pneumonia is the most significant cause of death in cattle greater than one month of age in Ireland. There are substantial long term implications of respiratory disease on productivity for both … Read more
Bolstering immunity with Bovilis Bovipast RSP: Reduce and control pneumonia in your herd
Frequently Asked Questions about Bovilis Bovipast RSP answered by Sarah Higgins, Ruminant & Equine Veterinary Manager
“Game changing” impact of Bovilis INtranasal RSP Live
County Wexford dairy farmer describes Bovilis INtranasal RSP Live as a “game changer” for the health of his calves Dermot Kehoe milks a 90-strong (mostly Holstein Friesian) herd with his wife Angela on their farm outside New Ross. The Kehoes also keep replacement heifers and 12 Aubrac cows. “We use the Aubrac bulls on the … Read more